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Abstract: Previous meta-analyses were conducted during the initial phases of the COVID-19
pandemic, which utilized a smaller pool of data. The current meta-analysis aims to provide additional
(and updated) evidence related to the psychological impact among healthcare workers. The search
strategy was developed by a medical librarian and bibliographical databases, including Medline,
Embase, CINAHL, PsycINFO, and Scopus were searched for studies examining the impact of the
COVID-19 pandemic on the psychological health of healthcare workers. Articles were screened by
three reviewers. Heterogeneity among studies was assessed by I2 statistic. The random-effects model
was utilized to obtain the pooled prevalence. A subgroup analysis by region, gender, quality of
study, assessment methods, healthcare profession, and exposure was performed. Publication bias was
assessed by Funnel plot and Egger linear regression test. Sixty-five studies met the inclusion criteria
and the total sample constituted 79,437 participants. The pooled prevalence of anxiety, depression,
stress, post-traumatic stress syndrome, insomnia, psychological distress, and burnout was 34.4%,
31.8%, 40.3%, 11.4%, 27.8%, 46.1%, and 37.4% respectively. The subgroup analysis indicated higher
anxiety and depression prevalence among females, nurses, and frontline responders than males,
doctors, and second-line healthcare workers. This study highlights the need for designing a targeted
intervention to improve resilience and foster post-traumatic growth among frontline responders.
Keywords: COVID-19; SARS-COV-2; psychological; anxiety; depression; stress; post-traumatic stress
syndrome; insomnia; burnout; fatigue
1. Introduction
In December 2019, a novel coronavirus originated in Wuhan (China), which was later identified
by the International Committee on Taxonomy of Viruses (ICTV) as SARS-CoV-2 causing the disease
COVID-19 [1]. The spread of the virus was rampant, with the cases spiraling up to nearly 148,838 in
March, which led to COVID-19 being designated as a pandemic by the World Health Organization
[WHO] on 11 March 2020 [2]. Undoubtedly, pandemics have a long-standing history of impacting
physical and mental health across all population groups, of which healthcare workers (HCWs) bear a
disproportionate burden [3]. During Severe Acute Respiratory Syndrome (SARS) and Middle East
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Respiratory Syndrome (MERS) outbreaks, a sizable proportion of the HCWs experienced anxiety,
emotional distress, and post-traumatic stress disorder (PTSD, aka fatigue battle syndrome) [4–6]. These
adverse psychological outcomes persisted until 1–3 years in the post-pandemic periods [6]. Following
the aggressive course of transmission, the COVID-19 pandemic has taken a firm grip worldwide and
has surpassed the historical outbreaks in generating extraordinary amounts of pressure and psychiatric
morbidities among healthcare workers (HCWs) [3,6–9]. Physical and emotional exhaustion associated
with managing large volumes of COVID-19 cases, shortage of personal protective equipment (PPE),
risk of nosocomial infections, and fear of secondary transmission to family members, feelings of being
rejected by others, and social isolation make frontline HCWs more vulnerable to the psychological
corollaries of the COVID-19 pandemic [7,8,10]. Similar to previous outbreaks, the stress induced by
this bio-disaster (COVID-19) has the potential to develop into PTSD [11–13]. In one Japan-based study,
stress associated with deployment activities among the healthcare workforce was investigated [11].
The symptoms of PTSD were reported among Disaster Medical Assistance Team (DMAT) members,
who were deployed to analyze, manage, and contain the transmission of COVID-19 on a Diamond
Princess Cruise ship during the initial phases of the pandemic [11,12]. PTSD has already been cited
as the main psychiatry disorder associated with disaster-related experiences or activities, especially
among those being on the front lines of the battle against the pandemic [13]. In the wake of the
COVID-19 pandemic, frontline responders are continuously working to meet the heavy healthcare
demands and are exposed to higher levels of psychiatric morbidities. It is likely that these psychiatric
issues will take a chronic course and will translate into PTSD in the repairing phases of the pandemic.
Therefore, it is critical to assess the psychological impact among HCWs throughout the evolution of
the COVID-19 pandemic to design early interventions to improve psychological outcomes. Several
qualitative and quantitative studies have been conducted to explore all dimensions of the psychological
spectrum among HCWs and provided valuable insights [11,13–15].
Previous meta-analyses investigated the psychological impact on healthcare populations during
the early episodes of this bio-disaster and utilized a smaller pool of data [14,15]. One (single-
arm) meta-analysis of observational studies included 13 studies [16–41] with a sample of
33,062 participants [14]. This study was based on a literature search on April 17, 2020. Another
meta-analysis attempted to expand the evidence (by adding 12 more studies) [29–40] by comparing the
psychological impact among the general population, healthcare workers, and patients with preexisting
conditions [15]. This study included a total of 19 studies [16–21,29–41] (based on a search on May
25, 2020), and the overall prevalence of psychological indicators among healthcare workers with no
further distinction based on exposure (i.e., frontline and second-line workers) were reported [15].
With the rapid evolution of pandemic and increased number of hospitalizations, frontline HCWs are
experiencing unprecedented emotional and psychological challenges [15,33–37]. Along the course of
the pandemic, new studies (n = 38) have rapidly been conducted in different parts of the world, [6,42–81],
which will provide additional insight into the existing literature. Additionally, it is imperative to make
continuous efforts in collecting and synthesizing more data until the full picture of the psychological
toll on healthcare workers emerges. Therefore, the purpose of this meta-analysis is to provide updated
evidence (based on search prior to July 27, 2020, with 40 additional studies) across 24 countries to
investigate the psychological impact of the COVID-19 pandemic on HCWs, with further stratification
to the level of COVID-19 exposure.
2. Materials and Methods
2.1. Protocol Registration
To conduct a meta-analysis on studies investigating the psychological impact of the COVID-19
pandemic among health care workers, we followed the Preferred Reporting Items for Systematic
Reviews and Meta-Analyses [PRISMA] guidelines [82]. This study protocol was registered in the
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International Prospective Register of Systematic Reviews (PROSPERO: CRD42020205824; https:
//www.crd.york.ac.uk/PROSPERO/).
2.2. Databases and Search Strategy
Information retrieval was conducted by a medical librarian (N.S.) on July 27, 2020. Our primary
database was MEDLINE. The MEDLINE strategy was developed, then peer-reviewed by colleagues
prior to being translated to other databases. The full search strategy is available in Appendix A.
We searched MEDLINE (Ovid) 1946–2020, Embase (embase.com) 1974–2020, CINAHL Complete
(EBSCOhost) 1937–2020, PsycINFO (EBSCOhost) 1872–2020, and Scopus (scopus.org) 1970–2020. For
preprints, we searched medRxiv (https://www.medrxiv.org/) and SSRN’s COVID-19 Research Topic
(https://www.ssrn.com/index.cfm/en/). The references of included publications and previous reviews
were also assessed to identify additional studies.
2.3. Eligibility Criteria
Quantitative and observational studies based on original research examining the impact of the
COVID-19 pandemic on the psychological health of HCWs were included. Studies which met the
following criteria were included: (1) directly related to the context of the impact of the COVID-19
pandemic and reported any or a combination of the psychological outcomes, including anxiety,
depression, stress, psychological distress, insomnia, and sleep disturbances; (2) non-interventional;
(3) conducted on a healthcare population; (4) published in the English language; (5) published between
December 1, 2019, to July 27, 2020; (6) used validated assessment methods or survey instruments to
record the psychological outcomes; (7) available as full-texts. We excluded studies if they: (1) were
irrelevant to the exposure (COVID-19) and the psychological outcomes; (2) were interventional; (3) were
conducted on a general population; (4) reported insufficient data with unclear methods; (5) were not in
the English language; (6) were conducted before December 1, 2019, and after July 27, 2020; (7) utilized
qualitative or mixed methods; (8) did not use validated survey tools; (9) were case reports, reviews,
editorials, duplicates, abstracts/poster-only records, animal studies, or biochemical studies.
2.4. Selection Process
Results were first exported into an EndNote library for deduplication and then imported to
Rayyan for screening. Three reviewers (K.B., T.P.S., and R.B.) performed screening independently and
did not know each other’s decisions. All articles first underwent title screening, and then advanced to
abstract screening, if deemed relevant. Then, the full texts of the selected abstracts were assessed to
determine the eligibility of articles for inclusion. If an article was not included, the reason for exclusion
was listed (Figure 1, PRISMA). If there were any disagreements, then the senior investigator (M.S.)
evaluated the article, and a consensus was achieved through discussion.
2.5. Data Extraction
Full texts of eligible articles were obtained for data abstraction. Three independent reviewers
(K.B., T.P.S., and R.B.) abstracted all studies for potential inclusion using a customized data abstraction
form. Inconsistencies between the three reviewers were adjudicated by a fourth, independent reviewer
(M.S.). The data elements included information about the author with year, study title, study location,
gender proportion, categories of healthcare occupations (if available), sample size, assessment methods
with the cut-off scores, and the prevalence of anxiety, depression, stress, psychological distress,
insomnia, and impaired sleep quality. Data related to each study were verified for accuracy; any
discrepancies were resolved through a discussion between the reviewers. We attempted to contact
corresponding authors of included records to obtain additional information when there was uncertainty
about study characteristics and data points.
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Figure 1. PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analysis) flow diagram
detailing the disposition of screened, included, and excluded records.
2.6. Assessment of Bias Risk
The quality assessment was performed by utilizing the National Institutes of Health (NIH) quality
assessment tool (https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools) to assess
the quality of the studies. Two reviewers (K.B. and T.P.S.) independently evaluated the risk of bias and
quality of the studies and rated them according to the tool’s dictionary and guidelines. After assessing
all the study components, the overall rating was determined using the criteria listed in the tool.
Based on the number of “yes” answers, a rating of good (7–9), medium (4–6), or poor (≤3) was assigned
to each study (Appendix B). Disagreements related to quality scores were resolved through a discussion
among the reviewers, and a consensus was achieved upon the final judgement offered by the senior
investigator (M.S.). The rating of two reviewers was compared, and the inter-rater agreement was
calculated using Microsoft Excel.
2.7. Statistical Analysis
The overall prevalence and 95% confidence intervals of psychological outcomes were pooled using
the Comprehensive Meta-Analysis Package (CMA version 3.0, Englewood, NJ, USA). The primary
effect measure was the proportions of events, such as anxiety, depression, stress, psychological distress,
insomnia, and impaired sleep quality. Due to methodologic variations and sample diversity across
studies, the random-effects model was used to extract the pooled estimate [83]. Heterogeneity was
assessed by the I2 statistic, which measures the percentage of variance resulting from true differences in
the effect sizes rather than the sampling error. Substantial heterogeneity [84] was defined as I2 > 50%.
Subgroup analysis (by potential sources of heterogeneity) was conducted according to the categorical
moderating variables: country (China vs. other countries), gender, continent (Asia vs. other continents),
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quality of the study (good/medium), assessment methods, health care profession (doctors vs. nurses),
type of exposure (high risk or frontline vs. low risk or second-line), and severity of psychological
symptoms (mild/moderate/severe). Sensitivity analysis was conducted to identify studies which may
severely affect the pooled prevalence. Funnel plot and Egger linear regression test was used to assess
publication bias [85]. Significant level was set as two-sided and p < 0.05.
3. Results
3.1. Study Screening
Our systematic search yielded 7255 potentially relevant papers (Figure 1), out of which
2768 duplicate studies were removed. The titles of the remaining 4487 records were screened,
and 4052 studies were excluded because the studies were conducted on non-healthcare population
(n = 1347), had a different outcome of interest (n = 1256), different study designs, including case
series, reviews, perspectives or opinions, and interventional studies (n = 1013), and were irrelevant
to the study’s objective (n = 436). This resulted in 435 papers, which were advanced to abstract
screening. A total of 321 papers were excluded after abstract screening because they were qualitative
or mixed studies (n = 68), studies on a general population (n = 73), studies without prevalence data
(n = 96), serological studies (10), or they were published as editorials, posters, or reviews (n = 74).
Full-text screening of the remaining 114 papers generated 65 articles, which were included in the final
review. Forty-nine articles were excluded in the final step because of following reasons: they were
abstracts-only or in other languages (n = 6), used non-validated questionnaires (n = 16), had an unclear
methodology or of low quality (n = 10), or had outcomes reported as means instead of the number of
cases/or proportions (n = 17) (Figure 1).
3.2. Study Quality
Twenty-nine studies were of good quality [16–19,24–28,31,34,39,41,42,44,46,53,54,57,59–61,63,64,
66,68,71,79,80] (score range 7–9) and thirty-six studies were of medium quality [6,20,21,23,27,29,30,32,
33,35–38,43,45,47–52,55,56,58,62,65,67,69,70,72–74,76–78,81] (score range: 4–6). The quality scores of
the included study evaluation as assessed using the National Institutes of Health quality assessment
tool are summarized (Table A2 in Appendix B). The ratings of two reviewers (K.B. and T.P.S.) were
averaged, and the inter-rater agreement was 84.5.
3.3. Study Characteristics
After deduplication and screening, 65 studies (Table A3 in Appendix C) [6,16–21,23–39,41–81]
with a total of 79,437 participants were included in the analysis. Among them, 51 were from Asia
(31 from China, 4 from India, 1 from Singapore, 1 from India and Singapore, 3 from Iran, two from
Pakistan, 2 from Jordan, 1 from Bahrain, 1 from Hong Kong, 1 from Israel, 1 from Nepal, 1 from Oman,
1 from Saudi Arabia, and 1 from South Korea), 10 were from Europe (3 from Italy, 4 from Turkey, 1 from
Switzerland, 1 from Serbia, and 1 from Ireland), 2 were from South America (1 from Argentina, Brazil,
Chile and Mexico, and one from Brazil alone), and 2 were from North America. All the studies were
cross-sectional and reported at least one psychological outcome (if not all) among HCWs in the context
of the COVID-19 pandemic. The median number of individuals per study was 582 (range: 37 to 11,118)
with a median male proportion of 25% (range: 0 to 96%) and a median response rate of 20.0% (range:
10.2% to 100%). Nearly 3/4th of the sample was female (n = 57,244; 72%). In terms of occupation
distribution, nurses constituted nearly 45.7% (n = 36,315), followed by physicians or doctors, forming
1/4th (n = 19,287) of the entire sample. Remaining professions include allied health staff, laboratory
specialists, anesthetist technicians and general technicians, physical therapists, pharmacists, dental
professionals, etc.
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3.4. Meta-Analysis
3.4.1. Anxiety Prevalence
The pooled prevalence of anxiety in 46 studies with a sample size 51,596 was 34.4% (Table 1,
Figure 2). The pooled prevalence of anxiety among good quality studies (n = 22) was 31.2% compared
to 38.1% among medium quality studies (n = 24) (Table 1). The pooled prevalence of anxiety in
the continent of Asia across 34 studies was 32.7% compared to 39.3% found in studies among other
continents. Twenty-two studies were conducted in China and had a pooled prevalence of 28.5% as
opposed to the 40.4% (Table 1) pooled prevalence across studies (n = 24) conducted in other countries.
The Generalized Anxiety Disorder survey questionnaire was used across 19 studies and a pooled
prevalence of 36.8% was found (Table 1). Gender data were available in seven studies with a pooled
prevalence of 46.9% for females and 44.2% for males. In groups by healthcare professions, the pooled
prevalence was higher in nurses compared to doctors (39.3% vs. 32.5%). Anxiety by exposure with a
pooled prevalence of 39.8% among frontline HCWs compared to 27.1% prevalence among second-line
HCWs. Levels of anxiety with the highest pooled prevalence of 60.3% related to mild symptoms,
followed by a 26.0% prevalence of moderate symptoms and a prevalence of only 14.3% for severe
symptoms (Table 1).
3.4.2. Depression Prevalence
The pooled prevalence of depression in 46 studies with a sample size 53,164 was 31.8% (Table 2,
Figure 3). The pooled prevalence of depression among good quality studies was 35.1%, compared
to 28.6% among medium quality studies (Table 2). The pooled prevalence of depression in the
continent of Asia was 30.8% compared to 35.0% found in other continents. Twenty-three studies were
conducted in China and had a pooled prevalence of 33.2% as opposed to the 30.4% pooled prevalence
across studies conducted in other countries (n = 23). The Patient Health Questionnaire (PHQ) was
used across 25 studies and a pooled prevalence of 29.7% was found. Gender data were available in
seven studies, with a pooled prevalence of 43.4% for females and 40.9% for males. In the healthcare
profession groups, examined in nine studies, the pooled prevalence of depression was higher in nurses
compared to doctors (42.4% vs. 39.1%). Depression by exposure was reported in six studies with a
pooled prevalence of 23.6% among frontline healthcare workers compared to 19.6% prevalence among
second-line healthcare workers. Levels of depression were reported in 17 studies, with the highest
pooled prevalence of 57.6% related to mild symptoms, followed by a 27.9% prevalence of moderate
and only 10.4% of severe symptoms (Table 2).
3.4.3. Stress Prevalence
The pooled prevalence of stress in 17 studies with a sample size of 16,235 was 40.3% (Table 3,
Figure 4). The pooled prevalence of stress among good quality studies (n = 9) was 37.3% compared
to 45.7% among medium quality studies (n = 8). The pooled prevalence of stress in the continent of
Asia across 14 studies was 41.3% compared to 38.8% found in other continents. Seven studies were
conducted in China and had a pooled prevalence of 44.2% as opposed to the 37.1% pooled prevalence
in studies conducted in other countries (n = 10). The Perceived Stress Scale (PSS) was used across eight
studies and a pooled prevalence of 61.4% was found. Levels of stress were reported in six studies,
with the highest pooled prevalence related to moderate symptoms of 52.3%, followed by a 25.8%
prevalence of mild and 18.9% of severe symptoms (Table 3). For stress, subgroup analyses by gender,
healthcare occupations, and risk exposure were not conducted due to inadequate data.
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Table 1. Subgroup analyses of anxiety across different categories.
Overall Number of Studies Proportion (%) 95% CI I2 p Value References
Anxiety prevalence 46 34.4% 29.5–39.7 99.1% <0.0001 [6,16–21,23–25,27–32,34,35,41–45,47–50,52,54,55,57,61,63–74,79–81]
Subgroup Analysis
Categories Subgroups Number of Studies Proportion (%) 95% CI I2 p Value References
Quality
Good 22 31.2% 24.5–38.7 99.2% <0.0001 [16–19,24,25,28,31,32,34,41,42,44,54,57,61,63,64,66,68,79,80]
Medium 24 38.1% 30.7–46.0 99.0% <0.0001 [6,20,21,23,27,29,30,35,43,47–50,52,55,65,67,69–74,81]
Continents
Asia 34 32.7% 27.1–38.8 99.2% <0.0001 [6,16–21,23–25,27–32,34,41–44,48,55,57,61,63,65,68–71,73,74,79]
Other 12 39.3% 29.6–49.9 97.8% <0.0001 [35,47,49,50,52,54,64,66,67,72,80,81]
Countries
China 22 28.5% 22.5–35.4 99.3% <0.0001 [16–20,23–25,27,28,30–32,41,42,57,63,68,70,71,73,79]
Other 24 40.4% 33.2–48.0 98.4% <0.0001 [6,21,29,34,35,43,44,47–50,52,54,55,61,64–67,69,72,74,80,81]
Assessment
GAD 19 36.8% 29.1–45.2 99.1% <0.0001 [6,16–18,25,31,35,41,49,50,61,63–67,70,72,74]
SAS 9 24.6% 16.1–35.6 99.7% <0.0001 [23,24,27,28,32,42,57,68,69]
Other 18 37.1% 29.1–45.9 99.0% <0.0001 [19–21,29,30,34,43–45,47,48,52,54,55,71,73,79–81]
Gender
Female 7 46.9% 38.6–55.3 84.6% <0.0001 [16,47–49,73,74,80]
Male 7 44.2% 36.3–52.5 93.2% <0.0001 [16,47–49,73,74,80]
Healthcare
Professions
Nurses 8 39.3% 27.5–52.6 98.9% <0.0001 [16,23,41,42,55,63,66,73]
Doctors 8 32.5% 21.9–45.2 98.9% <0.0001 [16,23,41,42,55,63,66,73]
Healthcare
Workers
Frontline 5 39.8% 24.1–58.0 98.6% <0.0001 [16,23,43,44,79]
Second-line 5 27.1% 15.1–43.7 99.0% <0.0001 [16,23,43,44,79]
Level of Anxiety
Mild 18 60.3% 53.8–66.4 94.8% <0.0001 [6,16,23,24,27,28,30,34,35,43,48,49,54,55,57,61,65,68]
Moderate 18 26.0% 21.4–31.3 95.4% <0.0001 [6,16,23,24,27,28,30,34,35,43,48,49,54,55,57,61,65,68]
Severe 18 14.3 11.2–18.1 97.1% <0.0001 [6,16,23,24,27,28,30,34,35,43,48,49,54,55,57,61,65,68]
CI = Confidence Interval; GAD = Generalized Anxiety Disorder; SAS = Self-rating Anxiety Scale; Good quality score = 7–9; Medium Quality score = 4–6; I2 statistic indicates
the heterogeneity.
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Table 2. Subgroup analyses of depression across different categories.
Overall Number of Studies Proportion (%) 95% CI I2 p Value References
Depression prevalence 46 31.8% 26.8–37.2 99.2% <0.001 [16–21,23,25,27,29–34,36,39,41,42,44–50,52,54,55,57,59,61,63–68,70–74,78–80]
Subgroup Analysis
Categories Subgroups Number of Studies Proportion (%) 95% CI I2 p Value References
Quality
Good 24 35.1% 27.6–43.5 99.5% <0.001 [16–19,25,27,31,32,34,39,41,42,44,46,54,57,59,61,63,64,66,68,79,80]
Medium 22 28.6% 21.6–36.7 97.9% <0.001 [20,21,23,29,30,33,36,45,47–50,52,55,65,67,70–74,78]
Continents
Asia 34 30.8% 25.1–37.1 99.4% <0.001 [16–21,23,25,27,29–34,39,41,42,44,46,48,55,57,59,61,63,65,68,70,71,73,74,78,79]
Other 12 35.0% 24.9–46.7 98.1% <0.001 [36,45,47,49,50,52,54,64,66,67,72,80]
Countries
China 23 33.2% 26.0–41.3 99.4% <0.001 [16–20,23,25,27,30–33,39,41,42,46,57,63,70,71,73,79]
Other 23 30.4% 23.6–38.3 98.7% <0.001 [21,29,34,36,44,45,47–50,52,54,55,59,61,64–67,72,74,78,80]
Assessment
PHQ 25 29.7% 23.1–37.2 99.4% <0.001 [16–18,29,31,33,36,39,41,45,46,49,50,59,61,63–66,68,70,72,74,78,79]
Other 21 34.7% 26.8–43.5 98.9% <0.001 [19–21,23,25,27,30,32,34,42,44,47,48,52,54,55,57,67,71,73,80]
Gender
Female 7 43.4% 33.6–53.9 95.8% <0.001 [16,47,48,59,73,74,80]
Male 7 40.9% 31.4–51.5 95.5% <0.001 [16,47,48,59,73,74,80]
Healthcare
Professions
Nurses 9 42.4% 30.4–55.4 99.0% <0.001 [16,23,33,41,42,55,63,66,73]
Doctors 9 39.1% 27.3–52.2 98.4% <0.001 [16,23,33,41,42,55,63,66,73]
Healthcare
Workers
Frontline 6 23.6% 14.1–36.7 99.1% <0.001 [16,17,21,23,44,79]
Second-line 6 19.6% 11.5–31.5 98.8% <0.001 [16,17,21,23,44,79]
Level of
Depression
Mild 17 57.6% 50.0–64.8 97.8% <0.001 [16,23,27,30,34,36,39,46,48,54,57,59,61,68,70,71,78]
Moderate 17 27.9% 22.1–34.6 97.9% <0.001 [16,23,27,30,34,36,39,46,48,54,57,59,61,68,70,71,78]
Severe 17 10.4% 7.0–14.0 97.8% <0.001 [16,23,27,30,34,36,39,46,48,54,57,59,61,68,70,71,78]
CI = Confidence Interval; PHQ = Patients Health Questionnaire; Good quality score = 7–9; Medium Quality score = 4–6; I2 statistic indicates the heterogeneity.
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Table 3. Subgroup analyses of stress across different categories.
Overall Number of Studies Proportion (%) 95% CI I2 p Value References
Stress prevalence 17 40.3% 31.4–50.0 99.1% <0.001 [18,20,21,31,32,34,41,44,48,54,58,60,62,64,66,73,76]
Subgroup Analysis
Categories Subgroups Number of Studies Proportion (%) 95% CI I2 p Value References
Quality
Good 9 37.3% 25.6–50.7 99.4% <0.001 [18,31,34,41,44,54,60,64,66]
Medium 8 45.7% 31.2–61.1 98.4% <0.001 [20,21,32,48,58,62,73,76]
Continents
Asia 14 41.3% 30.9–52.6 99.2% <0.001 [18,20,21,31,32,34,41,44,48,58,60,62,73,76]
Other 3 38.8% 20.6–60.8 99.1% <0.001 [54,64,66]
Countries
China 7 44.2% 30.9–58.4 99.5% <0.001 [18,20,31,32,41,73,76]
Other 10 37.1% 25.4–50.5 98.6% <0.001 [21,34,44,48,54,58,60,62,64,66]
Survey Instrument
PSS 8 61.4% 45.1–75.6 98.6% <0.001 [20,32,58,60,62,64,73,76]
DASS 5 17.5% 9.4–30.3 98.5% <0.001 [21,34,44,48,54]
Other 4 47.8% 29.3–66.8 99.7% <0.001 [18,31,41,66]
Level of Stress
Mild 6 25.8% 16.8–37.6 91.2% <0.001 [34,48,54,58,60,62]
Moderate 6 52.3% 38.7–65.5 95.8% <0.001 [34,48,54,58,60,62]
Severe 6 18.9% 11.9–28.9 93.4% <0.001 [34,48,54,58,60,62]
CI = Confidence Interval; PSS = Perceived Stress Scale; DASS = Depression Anxiety Stress Scale; Good quality score = 7–9; Medium Quality score = 4–6; I2 statistic indicates the heterogeneity.
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confidence intervals (CIs). The diamond represents the pooled prevalence and 95% CI of the overall
population. The overall pooled depression using a random effects DerSi onian-Laird method was
31.8% (95% CI: 26.8–37.2).
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Figure 4. Forest plot for the studies on the prevalence of stress among healthcare workers. The squares 
and horizontal lines correspond to the study-specific event (anxiety) rates and 95% confidence intervals 
(CIs). The diamond represents the pooled prevalence and 95% CIs of the overall population. The overall 
pooled stress using a random effects DerSimonian-Laird method was 40.3% (95% CI 31.4–50.0). 
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in a sample size of 2487 was 37.4% (95% CI: 14.8–67.2; I2 = 98.6%; p < 0.001; Figure A5 in Appendix C). 
  
Figure 4. Forest plot for the stu ies f tress a ong healthcare workers. The squares
and horizontal lines corres fi t (anxiety) rates and 95% confidence intervals
(CIs). The diamond represe t t a 95 CIs of the overall population. The overall
p oled stre s using a random effects erSi onian-Lair etho as 40. ( I . . ).
3.4.4. Prevalence of Insomnia and Impaired Sleep Quality
Under the random effects model, the overall prevalence of insomnia in a sample size of 18,546 was
27.8% (95% CI: 21.4–35.3, I2 = 98.1%; p < 0.001; Figure A1 in Appendix C across 11 studies [16–18,25,26,32,
44,63,64,76,79]. The insomnia severity index (ISI) was used across eight studies [17,18,26,32,44,63,64,79]
and a pooled prevalence of 62.8 (95% CI: 44.8–77.9; I2 = 98.2%; p value < 0.001) was found. In groups
by healthcare professions, three studies were included [16,18,63]. The pooled prevalence of insomnia
was slightly higher in nurses compared to doctors (42.4% vs. 39.1%). The quality of sleep was assessed
in five studies [26,32,58,66,70]. The overall prevalence of impaired sleep quality in a sample size of
2443 was 64.3% (95% CI:55.0–72.7, I2 = 93.1%; p < 0.001; Figure A2 in Appendix C). Subgroup analysis
for insomnia by gender and exposure was not conducted due to inadequate data.
3.4.5. Other Psychological Indicators
Post-traumatic stress disorder (PTSD) was assessed in six studies [21,24,34,64,71,77]. Under the
random effects model, the overall prevalence of PTSD in a sample size of 3676 was 11.4% (95% CI:
3.6–30.9; I2 = 99.2% p < 0.001; Figure A3 in Appendix C). Psychological distress was reported in
12 studies [16,23,28,29,37,38,49,51,53,56,57,60]. Under the random effects model, the overall prevalence
of psychological distress in a sample size of 30,963 was 46.1% (95% CI: 36.0–56.6; I2 = 99.6%; p < 0.001;
Figure A4 in Appendix C). Burnout was assessed in three studies [33,49,57] and the overall prevalence
in a sample size of 2487 was 37.4% (95% CI: 14.8–67.2; I2 = 98.6%; p < 0.001; Figure A5 in Appendix C).
3.4.6. Publication Bias
The publication bias was assessed with Egger’s test indices. As indicated by the p values for the
prevalence of anxiety (Egger test: p = 0.15), depression (p = 0.90), stress (p = 0.69), insomnia (p = 0.01),
impaired sleep quality (p = 0.22), PTSD (p = 0.22), psychological distress (p = 0.45), and burnout (p = 0.47)
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(Figure A6, Figure A7, Figure A8, Figure A9, Figure A10, Figure A11, Figure A12, Figure A13 in
Appendix C), the publication bias was insignificant for all the psychological outcomes, except insomnia.
4. Discussion
This pooled analysis included a large data sample of studies (n = 65) with 79,437 participants,
compared to previous meta-analyses that included 13–19 studies [14,15]. Notably, to our knowledge,
this study is the largest to evaluate the psychological impact of COVID-19 among HCWs. Moreover,
we extended the existing evidence by including other psychological outcomes of stress, psychological
distress, burnout, and impaired sleep quality. The findings suggest that the overall prevalence of
anxiety, depression, stress, insomnia was 34.4%, 31.8%, 40.3%, and 27.8%, respectively. Compared to
previous meta-analyses [14,15], we report a higher prevalence for anxiety (34.4% vs. 23.2%–26.0%),
depression (31.8% vs. 22.8%–25.0%), and PTSD (11.4% vs. 3%). The higher prevalence of anxiety,
depression, and PTSD may be explained by the pervading climate of uncertainty generated with
the advancing pandemic, limited signs of a workable vaccine, increased workload, lack of social
support, and an intense fear of family transmission [86–88]. According to a recent Chinese report
of 14,825 healthcare workers, depressive symptoms and PTSD were more common among HCWs
with lower levels of social support and longer daily working hours (>12 h/day) [88]. We found a
lower prevalence of insomnia compared to a previous analysis [14] (27.8% vs. 34.4%) despite having
a greater number of studies in the current analysis (11 vs. 5). This may be due to the variance in
the cut-off values (>14 vs. >8) of the ISI used by the recent studies, which were included in this
updated meta-analysis [32,44,63,64]. Moreover, the direction of the etiological relationships between
psychological morbidities and insomnia remains complex; for instance, anxiety disorders precede
insomnia in nearly 70% of the cases [89]. Therefore, it is likely that significant changes in sleep
architecture among HCWs will occur later and will be observed by prospective studies. In concordance
with previous studies, our subgroup analysis by gender revealed that females had a higher prevalence
of anxiety and depression compared to males [14,15,27,28,89–92]. The current meta-analysis found
higher levels of anxiety and depression among nurses compared to doctors, which may be because
nurses have closer and prolonged contact with patients compared to doctors [3,93]. We investigated the
prevalence of anxiety and depression by risk groups and found higher levels of anxiety and depression
(as expected) among frontline responders as compared to the second-line workers. All of these results
may be partly confounded by the fact that majority of the frontline workers’ group constitutes nurses,
who are responsible for providing direct care to the COVID-19 patients and for collecting sputum
specimen for virus detection, and tend to be female [3,27,28,94–97]. This repeats a finding from the
SARS outbreak that nurses reported higher anxiety, depression, behavioral problems, and moral
injuries (related to death and ethical dilemmas) [3,5,7,14,27,28,92–95]. These intersecting factors make
clear that it is imperative to develop interventions for the most vulnerable population: frontline nurses,
who tend to be female and work long hours. Our study reported a higher prevalence of anxiety in
other countries compared to China (40.4% vs. 28.5%). The reasons for this may be complex and could
be influenced by how other countries are directing their medical resources towards the containment
efforts or in treating infected patients rather than providing psychological services.
The higher prevalence of the psychosocial impact of COVID-19 on health care workers
found in this study draws more careful attention to educational and policy interventions for
this subgroup. Educational and behavioral interventions emphasizing hardiness, social support,
positive thinking, a sense of coherence, and others have been advocated in the literature [96–98].
The role of self-care is also highlighted by some researchers [98–100]. Positive traumatic growth
(a positive approach to the management of complex traumas) among health care workers has gained
special attention, and interventions to build this have been suggested [96,99,100]. Some strategies,
such as mindfulness interventions, can be instituted quickly to promote healthcare workers’ mental
health [97–99]. Organizational support is vital at the policy level and may need sufficient lead time
to be enacted [97–99]. Work-based interventions, such as curtailing hours of work, having buddy
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support systems, having listening sessions between administration and health care functionaries,
increasing coverage of tele counseling through employee assistance programs, having mental health
consultants available to staff through telehealth, and other such measures, can go a long way in
reducing the adverse psychosocial impact caused by COVID-19 [98,99].
4.1. Quality of Evidence
Compared to the previous reviews and meta-analyses, the current meta-analysis provides the most
extensive evidence with a much bigger sample size of 79,437 participants. Although all studies included
in our meta-analysis were cross-sectional, they were of high and medium quality. We performed
subgroup analyses to account for the potential sources of heterogeneity and to identify additional
vulnerabilities. Additionally, we investigated the potential for publication bias across all studies.
4.2. Study Limitations
There are a few limitations that merit discussion. First is the presence of heterogeneity across
studies in terms of the survey tool and cut-off scores. Additionally, threshold criteria for defining
levels of outcomes varied across studies; for example, some studies reported results as mild, moderate,
moderate-severe, and severe, while others reported outcomes as mild, moderate, and severe. This may
affect our subgroup analysis by severity. Second, data provided by the studies included in this
meta-analysis depend on the self-reported psychological outcomes as recorded through assessment
tools. Thus, there may be uncertainty related to the actual psychological illness or diagnosis. Third,
sampling bias may exist (although lower than the previous meta-analysis), because nearly 48% (31/65)
of the studies were conducted in China. This may also limit the generalizability of the results. Fourth,
all studies included in this meta-analysis were cross-sectional, which only provided a snapshot of the
existing situation with no exploration of longitudinal aspects. Last, we expect to have a language bias
in the study because only studies published in the English language were included.
4.3. Research and Clinical Implications
The findings of this meta-analysis highlight the need to develop psychological interventions to
promote the post-traumatic growth among HCWs. Higher prevalence estimates of stress provided by
this study have important implications for developing early interventions to prevent PTSD, which may
be higher in the repairing phases of the pandemic. Mental health and well-being interventions,
such as education on coping techniques, online wellness activities, fostering post-traumatic growth,
and opening channels for assistance in early signs of PTSS (Posttraumatic Stress Syndrome) before
they manifest to PTSD, are essential.
5. Conclusions
This article represents, to our knowledge, the most extensive meta-analysis to assess the
psychological impact of COVID-19 among HCWs. This meta-analysis provides additional evidence
to the higher psychological impact among HCWs, particularly those who are female, nurses,
and frontline responders. Furthermore, this adds a valuable insight to the existing meta-analysis
findings by highlighting a significant difference in the psychological impact across frontline and
second-line workers.
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Appendix A
Table A1. Database search strategies for psychological impact of COVID-19 among healthcare workers
(search date: 27 July 2020).
Database: Ovid MEDLINE(R) and Epub Ahead of Print, In-Process and Other Non-Indexed Citations and
Daily <1946 to 27 July 2020>
Search Strategy:
1. (2019nCoV or 2019-nCoV or coronavirus or coronavirinae or (corona adj3 (virinae or virus)) or “Corona
virinae19” or “Corona virinae2019” or “corona virus19” or “corona virus2019” or Coronavirinae19 or
Coronavirinae2019 or coronavirus19 or coronavirus2019 or covid19 or COVID-19 or SARS-CoV-2 or
“Severe Acute Respiratory Syndrome Corona virus 2” or “Severe Acute Respiratory Syndrome
Coronavirus 2”).ti,ab,kw. [covid-19 keywords] (46270)
2. coronavirus/or Coronavirus Infections/[covid-19 MeSH] (19104)
3. or/1–2 [covid-19 set] (48733)
4. mental health/or mental fatigue/or Affective Symptoms/or psychological distress/[Mental health MeSH]
(53257)
5. (emotional disturbanc* or affective symptom* or Alexithymia* or ((mental or psychological) adj3 (fatigue
or health or status or distress or well-being)) or psychosocial).ti,ab,kw. [mental health keywords] (283768)
6. or/4–5 [mental health set] (305532)
7. Stress, Psychological/or occupational stress/or compassion fatigue/or burnout, psychological/or burnout,
professional/[stress MeSH] (131108)
8. (stress* or “adaptation syndrome” or (caregiver adj4 (burden or fatigue)) or “compassion fatigue” or
“reality shock” or “social defeat”).ti,ab,kw. [stress keywords] (842732)
9. or/7–8 [stress set] (897231)
10. Depression/or anhedonia/[depression MeSH] (119688)
11. (depression or depressed or anhedonia or dysphoria or dysthymia or melancholia or sadness).ti,ab,kw.
[depression keywords] (404119)
12. or/10–11 [depression set] (436174)
13. anxiety/or catastrophization/[anxiety MeSH] (81955)
14. (anxiety or Catastrophiz* or hypervigilan* or nervousness).ti,ab,kw. [anxiety keywords] (195877)
15. or/13–14 [anxiety set] (218337)
16. “Sleep Initiation and Maintenance Disorders”/[insomnia MeSH] (13134)
17. (drowsiness or dyssomnia * or hypersomnia * or insomnia * or parasomnia *
The asterisk (“*”) used in the search string serves as a truncation operator.
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Appendix B
Table A2. Methodological quality assessment of included studies using the National Institutes of Health (NIH) tool.
Author/Year Q1 Q2 Q3 Q4 Q5 Q6 Q7 Q8 Q9 Q10 Q11 Q12 Q13 Q14 Final Quality Score Rating
Aksoy and Kocak et al., 2020 [81] Y Y NR N N Y N N Y NA Y NA NA N 5 Medium
Alshekaili et al., 2020 [44] Y Y Y Y N Y Y Y Y NA Y NA NA Y 8 Good
Amerio et al., 2020 [45] Y Y N N N Y Y Y Y NA N NA NA N 6 Medium
Amin et al., 2020 [37] Y Y Y N N Y N N Y NA Y NA NA N 5 Medium
An et al., 2020 [46] Y Y NR Y Y Y Y Y Y NA Y NA NA N 9 Good
Cai et al., 2020 [79] Y Y NR Y Y Y Y Y Y NA Y NA NA N 9 Good
Caliskan et al., 2020 [47] Y Y NR N N Y Y N Y NA Y NA NA N 6 Medium
Cao et al., 2020 [33] Y Y Y N N Y N N Y NA Y NA NA N 6 Medium
Chatterjee et al., 2020 [48] Y Y NR N N Y N Y Y NA Y NA NA N 6 Medium
Chen et al., 2020 [30] Y Y Y N N Y N N NR NA Y NA NA N 5 Medium
Chew et al., 2020 [34] Y Y Y N Y Y Y N Y NA Y NA NA N 8 Good
Chung and Yeung et al., 2020 [78] Y Y NR N N Y N N Y NA Y NA NA N 5 Medium
Civantos et al., 2020 [49] Y Y N N N Y Y N Y NA Y NA NA N 6 Medium
Consolo et al., 2020 [35] Y Y N N N Y Y N Y NA Y NA NA N 6 Medium
Corbett et al., 2020 [50] Y Y N N N Y Y N Y NA Y NA NA N 6 Medium
Dai et al., 2020 [51] Y Y Y N N Y Y N Y NA N NA NA N 6 Medium
Dal’Bosco et al., 2020 [52] Y Y N N N Y Y N Y NA Y NA NA N 6 Medium
Dong et al., 2020 [53] Y Y NR Y Y Y Y N Y NA Y NA NA N 8 Good
Du et al., 2020 [20] Y Y NR N N Y Y N Y NA Y NA NA N 6 Medium
Elbay et al., 2020 [54] Y Y NR Y Y Y Y N Y NA Y NA NA N 8 Good
Guiroy et al., 2020 [36] Y Y N N N Y Y N Y NA Y NA NA N 6 Medium
Guo et al., 2020 [23] Y Y NR N N Y Y N Y NA Y NA NA N 6 Medium
Hassannia et al., 2020 [55] Y Y Y N N Y Y N Y NA N NA NA N 6 Medium
Hawari et al., 2020 [56] Y Y NR N N Y Y N Y NA Y NA NA N 6 Medium
Hu et al., 2020 [57] Y Y Y Y Y Y Y N Y NA Y NA NA N 9 Good
Huang and Zhao et al., 2020 [25] Y Y Y Y Y Y Y N Y NA Y NA NA N 9 Good
Huang et al., 2020 [24] Y Y Y Y Y Y Y N Y NA Y NA NA N 9 Good
Jahrami et al., 2020 [58] Y Y Y N N Y N N Y NA Y NA NA N 6 Medium
Kang et al., 2020 [39] Y Y NR Y Y Y Y Y Y NA Y NA NA N 9 Good
Kaveh et al., 2020 [43] Y Y NR N N Y Y N Y NA Y NA NA N 6 Medium
Khanna et al., 2020 [59] Y Y NR Y Y Y Y N Y NA Y NA NA N 8 Good
Koksal et al., 2020 [80] Y Y NR Y Y Y Y N Y NA Y NA NA N 8 Good
Lai et al., 2020 [16] Y Y Y Y Y Y Y N Y NA Y NA NA N 9 Good
Li et al., 2020 [31] Y Y Y Y N Y Y N Y NA Y NA NA N 8 Good
Liu et al., 2020 [27] Y Y NR N N Y Y N Y NA Y NA NA N 6 Medium
Liu et al., 2020 [28] Y Y Y Y Y Y Y N Y NA Y NA NA N 9 Good
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Table A2. Cont.
Author/Year Q1 Q2 Q3 Q4 Q5 Q6 Q7 Q8 Q9 Q10 Q11 Q12 Q13 Q14 Final Quality Score Rating
Lu et al., 2020 [19] Y Y Y Y Y Y Y N Y NA Y NA NA N 9 Good
Nair et al., 2020 [60] Y Y NR Y N Y Y N Y NA Y NA NA N 7 Good
Naser et al., 2020 [61] Y Y NR Y N Y Y Y Y NA Y NA NA N 8 Good
Podder et al., 2020 [62] Y Y NR N N Y Y N Y NA Y NA NA N 6 Medium
Qi et al., 2020 [26] Y Y Y Y Y Y N N Y NA Y NA NA N 8 Good
Que et al., 2020 [63] Y Y NR Y Y Y Y Y Y NA Y NA NA N 9 Good
Rossi et al., 2020 [64] Y Y NR Y N Y Y Y Y NA Y NA NA Y 9 Good
Salman et al., 2020 [65] Y Y NR N N Y Y N Y NA Y NA NA N 6 Medium
Shacham et al., 2020 [38] Y Y NR N N Y Y N Y NA Y NA NA N 6 Medium
Shechter et al., 2020 [66] Y Y Y Y Y Y Y N Y NA Y NA NA N 9 Good
Stojanov et al., 2020 [67] Y Y NR N N Y Y N Y NA Y NA NA N 6 Medium
Sun et al., 2020 [77] Y Y NR N N Y Y N Y NA Y NA NA N 6 Medium
Tan et al., 2020 [21] Y Y Y N N Y Y N Y NA Y NA NA N 6 Medium
Temsah et al., 2020 [6] Y Y Y N N Y Y N N NA Y NA NA N 6 Medium
Teng et al., 2020 [68] Y Y N Y Y Y N Y Y NA Y NA NA Y 9 Good
Thapa et al., 2020 [69] Y Y NR N N Y N N Y NA Y NA NA N 5 Medium
Tu et al., 2020 [70] Y Y Y N N Y Y N N NA Y NA NA N 6 Medium
Wang et al., 2020 [32] Y Y Y Y N Y Y N Y NA Y NA NA N 8 Good
Wang et al., 2020 [71] Y Y Y N N Y Y N N NA Y NA NA N 6 Medium
Weilenmann et al., 2020 [72] Y Y NR N N Y Y N Y NA Y NA NA N 6 Medium
Xiao et al., 2020 [73] Y Y NR N N Y N Y Y NA Y NA NA N 6 Medium
Yang et al., 2020 [74] Y Y Y N N Y N N Y NA Y NA NA N 6 Medium
Yin et al., 2020 [75] Y Y Y Y Y Y Y N Y NA Y NA NA N 9 Good
Zhan et al., 2020 [76] Y Y Y N N Y Y N N NA Y NA NA N 6 Medium
Zhang et al., 2020 [17] Y Y NR Y Y Y Y Y Y NA Y NA NA N 9 Good
Zhang et al., 2020 [18] Y Y Y Y Y Y Y N Y NA Y NA NA N 9 Good
Zhang et al., 2020 [29] Y Y NR N N Y Y N Y NA Y NA NA N 6 Medium
Zhu et al., 2020 [41] Y Y Y Y Y Y Y N Y NA Y NA NA N 9 Good
Zhu et al., 2020 [42] Y Y Y Y N Y Y N Y NA Y NA NA N 8 Good
Y: Yes, N: No, NR: Not reported, NA: Not applicable. (Q1. Was the research question or objective in this paper clearly stated? Q2. Was the study population clearly specified and defined?
Q3. Was the participation rate of eligible persons at least 50%? Q4. Were all the subjects selected or recruited from the same or similar populations (including the same time period)? Were
inclusion and exclusion criteria for being in the study prespecified and applied uniformly to all participants? Q5. Was a sample size justification, power description, or variance and effect
estimates provided? Q6. For the analyses in this paper, were the exposure(s) of interest measured prior to the outcome(s) being measured? Q7. Was the timeframe sufficient so that one
could reasonably expect to see an association between exposure and outcome if it existed? Q8. For exposures that can vary in amount or level, did the study examine different levels of the
exposure as related to the outcome (e.g., categories of exposure, or exposure measured as continuous variable)? Q9. Were the exposure measures (independent variables) clearly defined,
valid, reliable, and implemented consistently across all study participants? Q10. Was the exposure(s) assessed more than once over time? Q11. Were the outcome measures (dependent
variables) clearly defined, valid, reliable, and implemented consistently across all study participants? Q12. Were the outcome assessors blinded to the exposure status of participants? Q13.
Was loss to follow-up (response rate) after baseline 20% or less? Q14. Were key potential confounding variables measured and adjusted statistically for their impact on the relationship
between exposure(s) and outcome(s)? Rating—Good, Medium or Poor), Good = (7–9 yes); Medium = (4–6 yes).)
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Appendix C
Table A3. Characteristics of studies meeting the search inclusion criteria.




(%) Depression Anxiety Insomnia Stress PTSD
a Distress
Aksoy and Kocak et al.,
2020 [81] 758 Turkey 0.0 100.0 7.0 STAI
y NA ae NA 36.3(275) NA NA NA NA
Alshekaili et al., 2020 [44] 1139 Oman 33.7 39.4 20.0
DASS t -21(D aa)
DASS t -21(A ab)














Amerio et al., 2020 [45] 131 Italy NA NA 51.9 PHQ c -9 ≥10 39.3(30) NA NA NA NA NA
Amin et al., 2020 [37] 250 Pakistan 49.2 30.4 63.6 PGWBI l ≥30 NA NA NA NA NA
72.4
(181)
An et al., 2020 [46] 1103 China 0.0 100.0 9.2 PHQ c -9 ≥5 43.6(481) NA NA NA NA NA












(902) NA NA NA








(103) NA NA NA NA
Cao et al., 2020 [33] 37 China 16.0 19.0 21.6 PHQ c -9 ≥10 18.9(7) NA NA NA NA NA













(19) NA NA NA NA
Chew et al., 2020 [34] 906 Singaporeand India NA NA NA
DASS t -21(D aa)
DASS t -21(A ab)














Chung and Yeung et al.,
2020 [78] 69 Hong Kong 4.4 34.8 NA PHQ
c -9 ≥10 49.3(34) NA NA NA NA NA










(167) NA NA NA
60.2
(210)
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Table A3. Cont.




(%) Depression Anxiety Insomnia Stress PTSD
a Distress
Consolo et al., 2020 [35] 356 Italy NA NA 60.4 GAD b -7 ≥5 NA
57.0
(204) NA NA NA NA








(51) NA NA NA NA
Dai et al., 2020 [51] 4357 China 32.6 53.8 23.5 GHQ e -12 ≥3 NA NA NA NA NA 39.1(1704)
Dal’Bosco et al., 2020 [52] 88 SouthAmerica NA NA 10.2 HAD
k ≥3 25.0(22)
48.9
(43) NA NA NA NA
Dong et al., 2020 [53] 4618 China 24.6 62.7 16.3 HEI q ≥8 NA NA NA NA NA 24.2(1118)













Elbay et al., 2020 [54] 442 Turkey NA NA 43.2
DASS t -21(D aa)
DASS t -21(A ab)










Guiroy et al., 2020 [36] 204 LatinAmerica ad 100.0 NA 96.6 PHQ
c -9 ≥10 100(204) NA NA NA NA NA








(1940) NA NA NA
40.7
(4530)
Hassannia et al., 2020 [55] 487 Iran 26.08 21.56 NA HADS
k -D aa






(306) NA NA NA NA
Hawari et al., 2020 [56] 1006 Jordan 13.02 63.02 44.7 K6 ag ≥11 NA NA NA NA NA 96.5(971)








(833) NA NA NA
41.5
(835)
Huang and Zhao et al.,












(531) NA NA NA













≥14 NA NA NA
100.0
(257) NA NA
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a Distress










(627) NA NA NA NA NA
Kaveh et al., 2020 [43] 1038 Iran 20.6 63.3 12.4 BAI m ≥7 NA 100.0(1038) NA NA NA NA
Khanna et al., 2020 [59] 2355 India NA NA 56.6 PHQ c -9 ≥4 32.6(765) NA NA NA NA NA
Koksal et al., 2020 [80] 702 Turkey NA 48.3 30.0 HADS
k -D aa






(404) NA NA NA NA






























Liu et al., 2020 [27] 512 China NA NA 15.4 SAS r ≥50 NA 12.5(64) NA NA NA NA










(749) NA NA NA
15.9
(744)
Lu et al., 2020 [19] 2299 China 88.8 NA 22.4 HADS
k -D aa






(569) NA NA NA NA

















(823) NA NA NA NA
Podder et al., 2020 [62] 384 India NA NA 55.5 PSS j -10 ≥13 NA NA NA
100
(384) NA NA






(594) NA NA NA
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(657) NA NA NA





























(85) NA NA NA NA
Shacham et al., 2020 [38] 338 Israel NA NA 41.4 K6 ag ≥19 NA NA NA NA NA 11.5(39)



















(97) NA NA NA NA
Sun et al.,2020 [77] 320 China NA NA NA PCL af -5 ≥33 NA NA NA NA
4.4
(14) NA
Tan et al., 2020 [21] 470 Singapore 28.7 34.3 31.7
DASS t -21(D aa)
DASS t -21(A ab)














Temsah et al., 2020 [6] 582 SaudiArabian 18.6 62.4 24.9 GAD
b -7 ≥5 NA
100.0
(582) NA NA NA NA








(56) NA NA NA NA
Thapa et al., 2020 [69] 100 Nepal 9.0 62.0 22.0 SAS r ≥45 NA 34.0(34) NA NA NA NA










(40) NA NA NA NA
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(%) Depression Anxiety Insomnia Stress PTSD
a Distress
Wang et al., 2020 [71] 1045 China 14.3 74.0 14.2
HADS k -D aa























(365) NA NA NA NA
Xiao et al., 2020 [73] 958 China 39.5 37.5 32.8 HADS
k -D aa






(518) NA NA NA NA








(21) NA NA NA NA
Yin et al., 2020 [75] 371 China 18.1 71.2 38.5 PCL af -5 ≥33 NA NA NA NA
3.8
(14) NA
























(739) NA NA NA

























(85) NA NA NA
20.1
(61)





















(33) NA NA NA NA
a PTSD: Post-traumatic stress syndrome, b GAD: Generalized anxiety disorder scale, c PHQ: Patient health questionnaire, d ISI: Insomnia severity index, e GHQ: General health
questionnaire, f AIS: Athens insomnia scale, g FS: Fatigue scale, h CPSS: Chinese perceived stress scale, i IES: Impact of event scale, j PSS: Perceived stress scale, k HAD: Hospital anxiety
depression scale, l PGWBI: Psychological General Well-Being Index, m BAI: Beck anxiety Inventory, n SCL-19-R: Symptom checklist, o BDI: Beck depression inventory, p PSQI: Pittsburgh
sleep quality index, q HEI: Huaxi emotional distress index, r SAS: Self-rating anxiety scale, s CES-D: The center for epidemiology scale for depression, t DASS: Depression, anxiety, stress
scales, u PC-PTSD: Primary care PTSD Screen, v Zsds: Zung self-rating depression scale, w CPDI: COVID-19 Peri traumatic distress index, x SRQ: Self reporting questionnaire, y STAI:
State-trait anxiety inventory, z SDS: Self-rating depression scale, aa D: Depression, ab A: Anxiety, ac S: Stress, ad Latin America: Countries included Brazil, Argentina, Chile, and Mexico,
ae NA: Not applicable, af PCL: Post-traumatic stress disorder checklist, ag K6—Kessler Phycological Distress Scale.
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Figure A1. Forest plot for the studies on the prevalence of insomnia among healthcare workers. The 
squares and horizontal lines correspond to the study-specific event (anxiety) rates and 95% confidence 
intervals (CIs). The diamond represents the pooled prevalence and 95% CI of the overall population. 
The overall pooled insomnia using a random effects DerSimonian-Laird method was 27.8% (95% CI: 
21.4–35.3). 
 
Figure A2. Forest plot for the studies on the prevalence of impaired sleep quality among healthcare 
workers. The squares and horizontal lines correspond to the study-specific event (anxiety) rates and 
95% confidence intervals (CIs). The diamond represents the pooled prevalence and 95% CI of the 
overall population. The overall pooled impaired sleep quality using a random effects DerSimonian-
Laird method was 64.3% (95% CI: 55.0–72.7). 
 
Figure A3. Forest plot for the studies on the prevalence of Post-traumatic stress syndrome (PTSD) 
among healthcare workers. The squares and horizontal lines correspond to the study-specific event 
(anxiety) rates and 95% confidence intervals (CIs). The diamond represents the pooled prevalence 
and 95% CI of the overall population. The overall pooled PTSD using a random effects DerSimonian-
Laird method was 11.4% (95% CI: 3.6–30.9). 
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confidence intervals (CIs). The diamond represents the pooled prevalence and 95% CI of the overall
population. The overall pooled insomnia using a random effects DerSimonian-Laird method was 27.8%
(95% CI: 21.4–35.3).
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Figure A2. Forest plot for the studies on the prevalence of impaired sleep quality among healthcare
workers. The squares and horizontal lines correspond to the study-specific event (anxiety) rates and
95% confidence intervals (CIs). The diamond represents the pooled prevalence and 95% CI of the overall
population. The overall pooled impaired sleep quality using a random effects DerSimonian-Laird
method was 64.3% (95% CI: 55.0–72.7).
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Figure A3. Forest plot for the stu i e f ost-traumatic stres syndrome (PTSD)
among healthcare workers. The s tal lines co respond to the study-specific event
(anxiety) rates and 95% confidence intervals (CIs). The diamond repres nts the pooled prevalence and
95% CI of the verall population. The overall pooled PTSD using a random effects DerSimonia -Laird
method was 11.4% (95% CI: 3.6–30.9).
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workers. The squares and horizontal lines correspond to the study-specific event (anxiety) rates and 
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overall population. The overall pooled psychological distress using a random effects DerSimonian-
Laird method was 46.1% (95% CI: 36.0–56.6). 
 
Figure A5. Forest plot for the studies on the prevalence of burnout among healthcare workers. The 
squares and horizontal lines correspond to the study-specific event (anxiety) rates and 95% confidence 
intervals (CIz). The diamond represents the pooled prevalence and 95% CI of the overall population. 
The overall pooled burnout using a random effects DerSimonian-Laird method was 37.4% (95% CI: 
14.8–67.2). 
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. Forest plot for the studies on the preval nce of burnout among e lthcare workers.
The squ res and horizo tal lin correspond to the study-specific event ( nxiety) rates an 95%
confidence intervals (CIz). Th diamond r presents the pooled prevalence and 95% CI of the overall
population. The overall pooled burnout using a random effects DerSimonian-Laird method was 37.4%
(95% CI: 14.8–67.2).
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Figure A6. Funnel plot for studies on the prevalence of anxiety (Egger test: P = 0.15; Begg test: P = 
0.90). The vertical solid line represents the summary effect estimates. 
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Figure A8. Funnel plot for studies on the prevalence of stress (Egger test: P = 0.69; Begg test: P = 0.86). 
The vertical solid line represents the summary effect estimates. 
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Figure A6. Funnel plot for studies on the prevalence of anxiety (Egger t st: P = 0.15; Begg test: P = 0.90).
The vertical solid line represents th summary effect stimates.
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Figure A7. Funnel plot for studies on the prevalence of depression (Egger test: P = 0.90; Begg test:
P = 0.64). The vertical solid line represents the summary effect estimates.
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Begg test: P = 0.22). The vertical solid line represents the summary effect estimates. 
 
Figure A11. Funnel plot for studies on the prevalence of PTSD (Egger test: P = 0.22; Begg test: P = 0.90). 
The vertical solid line represents the summary effect estimates. 
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Funnel plot for studies on the prevalence of insomnia (Egger test: P = 0.01; Begg test:
P = 0.03). The vertical solid line repre ents the summary effect estimates.
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Figure A11. Funnel plot for studies on the prevalence of PTSD (Egger test: P = 0.22; Begg test: P = 0.90). 
The vertical solid line represents the su ary effect esti ates. 
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Figure A12. Funnel plot for studies on the prevalence of psychological distress (Egger test: P = 0.45; 
Begg test: P = 0.73). The vertical solid line represents the summary effect estimates. 
 
Figure A13. Funnel plot for studies on the prevalence of burnout (Egger test: P = 0.47; Begg test: P = 
0.60). The vertical solid line represents the summary effect estimates. 
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Funnel plot for studies on the prevalence of burnout (Egger est: P = 0.47; Begg test:
P = 0.60). The vertical solid line repre ents the summary effect estimates.
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